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Summary   
FUsed in Sarcoma (FUS) is an RNA binding protein involved in regulating many aspects of RNA processing 
and linked to several neurodegenerative diseases. Transcriptomics studies indicate that FUS binds a large variety 
of RNA motifs, suggesting that FUS RNA binding might be quite complex.  
Here, we present solution structures of FUS zinc finger (ZnF) and RNA recognition motif (RRM) domains 
bound to RNA. These structures show a bipartite binding mode of FUS comprising of sequence-specific 
recognition of a NGGU motif via the ZnF and an unusual shape recognition of a stem-loop RNA via the RRM. 
In addition, sequence independent interactions via the RGG repeats significantly increase binding affinity and 
promote destabilization of structured RNA conformation enabling additional binding. We further show that 
disruption of the RRM and ZnF domains abolishes FUS function in splicing. Altogether, our results rationalize 
why deciphering the RNA binding mode of FUS has been so challenging.  
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Introduction 
FUS is a multi-functional heterogenous nuclear ribonucleoprotein (hnRNP) involved in many aspects of RNA 
homeostasis including transcription, splicing and miRNA biogenesis (Schwartz et al., 2012; Schwartz et al., 
2013). A component of many RNP granules, including stress granules and neuronal transport granules (Kanai et 
al., 2004), FUS is particularly adept at undergoing phase separation, a process thought to contribute to RNP 
granule integrity in cells (Burke et al., 2015; Murakami et al., 2015; Patel et al., 2015).  
The two neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar 
degeneration (FTLD) show neuropathological protein aggregates containing FUS and it is hypothesized that 
mis-regulation of RNA processing could play a major role in these diseases (Ling et al., 2013; Ramaswami et 
al., 2013). ALS is a devastating disease affecting motor neurons, resulting in fatal muscular atrophy and over 
fifty point mutations in FUS have been discovered in the familial forms of ALS especially in the nuclear 
localization sequence (NLS) (Guerrero et al., 2016; Shang and Huang, 2016). FTLD is the second most common 
dementia following Alzheimer’s disease and is characterized by progressive changes in behavior, personality 
and language (Neumann et al., 2009). In FTLD patients, FUS protein also accumulates in aggregates in the 
absence of mutations along with two related FET protein family members (Neumann et al., 2011), EWS 
(Ewing’s Sarcoma protein) and TAF15 (TATA box binding protein associated factor). All three proteins show 
decreased levels of arginine methylation within RGG regions preventing correct nuclear localization and 
increasing aggregation propensity. In contrast,decreased arginine methylation is not observed in ALS-FUS 
indicating that these two diseases may proceed through distinct molecular mechanisms (Dormann et al., 2012; 
Hofweber et al., 2018).  
ALS-linked mutations are almost absent from the folded RNA binding domains (RBD) and RBD 
mutants diminish the toxicity of FUS bearing ALS linked mutant in a fly model of ALS (Daigle et al., 2013). 
Accordingly, detailed characterization of FUS interaction with RNA is important to fully understand FUS 
function and to potentially suggest strategies for alleviating FUS pathogenicity. FUS shows widespread co-
transcriptional binding to RNA, associating with a large variety of RNAs classes (Ishigaki et al., 2012; Nakaya 
et al., 2013; Zhou et al., 2013).  Binding data showed that FUS can bind many different RNAs promiscuously in 
a length dependent manner (Ozdilek et al., 2017; Wang et al., 2015) yet a robust specificity has remained 
elusive. 
FUS possesses a N-terminal prion-like region which is involved in protein interactions and liquid-
liquid phase separation (Burke et al., 2015; Murray et al., 2017). The C-terminal region is implicated in RNA 
binding and consists of two globular domains, an RNA recognition motif (RRM) and a zinc finger (ZnF), which 
are interspersed between three regions rich in RGG repeats. A C-terminal NLS direct nucleo-cytoplasmic 
localization (Dormann et al., 2012). EWS and TAF15, have similar domain structures and appear to cross 
regulate the expression levels between them. The ZnF belongs to the small family of RanB2 ZnFs comprised of 
zinc ribbon-like domains with two crossed E-hairpins and a zinc atom bound by four cysteines. A subset of these 
domains have been shown to bind RNA (Iko et al., 2004; Nguyen et al., 2011). The role of the RRM in RNA 
recognition is less clear, with contradictory reports on its capacity to bind RNA (Iko et al., 2004; Liu et al., 
2013). The FUS RRM has a classic β1α1β2β3α2β4 fold with the addition of a β hairpin (β’β”) between α1 and 
β2, which is unique among RRMs and conserved in FET family members (Liu et al., 2013) and a non-canonical 
RNP1, a signature sequence of the RRM involved in RNA binding. The RGG-rich regions of FUS have a dual 
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role, they can bind RNA, such as promoter associated prD (Schwartz et al., 2013) or structured telomeric G-
quadruplexes (Takahama et al., 2013, Takahama et al, 2015), but when methylated, can also bind proteins, such 
as SMN (survival motor neuron) and can also independently promote phase separation (Guo et al., 2018; 
Hofweber et al., 2018; Qamar et al., 2018; Yoshizawa et al., 2018).  
In order to unravel the contributions of the various domains of FUS for RNA binding, we have 
investigated RNA binding with a FUS construct comprising of of  the RRM, the ZnF and the intervening RGG 
repeat, to many of the proposed RNA motifs or targets. Our NMR chemical shift perturbation experiments 
revealed that both, the ZnF and the RRM, bind RNA and that each domain has a distinct RNA binding 
preference. The ZnF specifically binds GGU containing RNAs whereas the RRM binds with a broader 
specificity. The structure of the RRM bound to a stem-loop RNA revealed a very unusual binding mode for an 
RRM, binding the 3’ side of the RNA loop with limited sequence specificity using its β-sheet and the C-terminal 
helix and contacting the RNA stem by insertion of its unusual β-hairpin (β’β”) into the RNA major groove. 
Additionally, we found that the RGG repeats contribute significantly to the affinity for RNA and disrupts base 
stacking present in the 5’ side of the RNA loop. Mutation of the RNA binding surface of the RRM and ZnF 
show that both domains can contribute to minor intron splicing whereas the ZnF contributes to autoregulation of 
FUS and cross regulation of TAF15 expression levels. These results provide the first structural insights into how 
this enigmatic protein FUS recognizes RNA.  
  
Results 
The RRM and ZnF of FUS have different RNA-binding specificities 
We expressed the region of FUS (269-454), encompassing the RRM, the ZnF and the intervening RGG region 
(RGG2) in order to analyze the RNA binding specificity of FUS (Figure 1A, Figure S1). The 1H-15N-HSQC of 
this construct revealed dispersed cross-peaks corresponding to the folded RRM and ZnF, along with cross-peaks 
with little chemical shift dispersion centered at around 8 ppm from RGG2. Low and negative 1H-15N NOE 
further confirmed that RGG2 region is highly dynamic and disordered (Figure S1A). 
Several different RNA motifs have been proposed as targets for FUS, whereas other studies propose 
that FUS binds promiscuously We titrated FUS RRM-RGG2-ZnF (269-454) with several RNAs including stem-
loop RNAs (Hoell et al., 2011), CG-rich (Ray et al., 2013), AUU-rich (Hoell et al., 2011) and a GGU-containing 
RNA (Lagier-Tourenne et al., 2012; Lerga et al., 2001; Rogelj et al., 2012), and with ssDNA motifs (Tan et al., 
2012) (Figure S1B-D). NMR chemical shift differences were monitored to identify which regions are involved 
in binding the various RNA targets. Titration of the stem-loop RNA from SON and hnRNPA2/B1 pre-mRNA 
including the UA-Y motif at the stem-loop junction (Hoell et al., 2011), shows binding by the RRM but not to 
the ZnF (Figure 1B top, Figure S1B). The RRM also binds single stranded RNA (ssRNA) of widely different 
sequences including CG- and AUU-rich RNAs, suggesting that the RRM has a broad binding specificity 
(Figure 1B, Figure S1C). Within the RRM, the same residues are involved in RNA binding, indicating that for 
all three RNAs the same RNA binding surface is involved, but not necessarily in the same manner (Figure 1C). 
This is illustrated by the chemical shift perturbations of specific residues, such N284, that show clear differences 
in magnitude and direction of shifts with GC vs AUU rich RNAs, and T317 which shows larger chemical shift 
perturbations when binding RNA stem-loops (Figure 1C, Figure S1B-C). In contrast, upon addition of the 
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UGGUA motif, chemical shift perturbations are only observed in the ZnF (Figure 1B), indicating that binding is 
sequence-specific. The RGG-rich interdomain linker shows little chemical shift change for all RNAs tested, yet 
it does undergo a reduction in reorientation motions when FUS is bound to the stem-loop as shown by 1H-15N 
NOE (Figure S1A, bottom). Together, these data establish that the FUS RRM and ZnF each bind in a very 
distinct manner in terms of both structure and sequence. By inspecting the sequences surrounding the stem-loop 
motif bound by FUS in PAR-CLIP (Hoell et al., 2011), we identified the presence of neighboring GGU motifs 
upstream or downstream in numerous pre-mRNAs including SON and hnRNPA2/B1. Binding of FUS (269-454) 
to the SON pre-mRNA containing the stem-loop and a downstream GGU revealed that both RRM and ZnF 
domains are bound simultaneously (see chemical shift perturbation of T317 and K427 (Figure 1B and 1C, 
Figure S1E, top)). Similar results were obtained with hnRNPA2/B1 stem-loop which has an upstream GGU 
motif (Figure S1E, bottom), strongly suggesting that each domain of FUS can bind their respective motifs when 
both are present in the same RNA. 
 
Structural basis for RNA recognition by the zinc finger of FUS  
In order to understand the molecular basis of RNA recognition by FUS, we determined the structures of the two 
folded RNA binding domains (ZnF and RRM) bound to one of their targets using NMR spectroscopy. 1H-15N 
HSQC spectra of individual domains bound to their target RNAs (UGGUG for the ZnF and a stem-loop for the 
RRM) were almost identical to FUS (269-454) bound to the same RNAs (Figure S1F,H-I) and therefore we 
used spectra of the individual complexes to determine the 3D structures. 
We first determined the structure of the ZnF (aa 418-454) bound to UGGUG (Figure 2). Using 74 
intermolecular NOE-based distance constraints (Figure 2B, Figure S2A, Table S1), we could calculate a 
precise structural ensemble of the complex (Figure 2C, Table 1). The ZnF binds only UGGU (Figure 2D), as 
we do not detect contacts to G5 (Figure 2C). G2 and G3 stack on each side of F438 (Figure 2C), consistent with 
the large upfield shifts of this side chain (Figure S2B). The N-terminal residues Q420-Q421-R422 fold upon 
binding to interact with G2, resulting in G2 being sandwiched between R422 and F438 and recognized by four 
hydrogen bonds with D425 and W440 side chains and S439 main chain (Figure 2E). G3 stacks with F438 and 
U4, with its Hoogsteen edge recognized by R441 side chain and its Watson-Crick edge by M436 and F438 main 
chains (Figure 2F). Both the exchangeable imino resonances of G2 and G3 are observable consistent with direct 
hydrogen bonding and each gave rise to several intermolecular NOEs (Figure S2A middle). In comparison, the 
two flanking uracils are more solvent exposed. U4 contacts the side chains N435 and N445, both of which 
recognize U4 in a sequence-specific manner (Figure 2F). The hydrogen bonds are consistent with the 
observation of an additional protected imino group in the 1D spectrum (Figure S2A middle) which could arise 
from the imino of U4. U4 also stacks with Q446 consistent with upfield shifts of the NH2 groups of this residue 
(Figure 2A). In contrast, U1 contacts the ZnF by stacking with W440, in a sequence independent interaction. 
The presence of U1 changes the NMR exchange regime from fast to intermediate in 1H-15N HSQC titrations 
demonstrating a direct contribution to binding (Figure S2D). Overall, the structure is consistent with a 
sequence-specific recognition of a NGGU motif where N can be any ribonucleotide (A,C,T or G). 
The NGGU motif is a short motif present within slightly longer CLIP derived GUGGU and SELEX 
derived GGUG motifs. Natural abundance 1H-13C HSQC of RNA do not show chemical shift perturbations in 
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the flanking guanines G0 in GUGGU and G5 in UGGUG on binding ZnF and no additional intermolecular NOE 
to these nucleotides were detected (Figure S2C and data not shown). Interestingly chemical shift perturbations 
were observed for A5 of UGGUA at low temperature suggesting a potential interaction (Figure S2E), however, 
again no intermolecular NOEs could be detected. ITC measurements showed similar binding affinities of the 
ZnF for both UGGUG and UGGUA, in agreement with the final guanine not being bound in a sequence-specific 
manner (Figure S2F, Table S3). Our structure is in excellent agreement with a previously published binding 
assay (Nguyen et al., 2011) and the mode of recognition is likely to be conserved in EWS and TAF15 ZnFs, 
considering the high sequence conservation between residues involved in interacting with RNA (Figure 2G). 
Stem-loop RNA recognition by FUS RRM  
As shown above, the RRM binds RNA with a broad specificity (Figure 1). However, the best quality NMR 
spectra (Figure 3A) and largest chemical shift differences (Figure 3B) were obtained with the RRM bound to 
the stem-loop from hnRNP A2/B1 pre-mRNA (Hoell et al., 2011). Using 70 NOE-derived intermolecular 
distance constraints found in the RRM bound to hnRNPA2/B1 stem loop and confirmed in a complex with a 
deletion (ΔA11) in the loop region of the RNA (Figure S3A-C, Table S2), we obtained a precise structural 
ensemble (Table 1, Figure 3C). The RRM binds primarily four nucleotides (A12, U13, U14 and C15) in the 3’ side 
of the nine-nucleotide loop (Figure 3D). The 5’ side of the loop shows extensive intramolecular stacking 
(Figure 3D) reflective of sequential intra-RNA NOEs in this region. The binding site of the RRM is a rather 
unexpected, since the proposed binding motif identified by PAR-CLIP included a UA motif in the 5’ side of the 
loop (Hoell et al., 2011), which, at position U8A9, is not bound by the RRM in this structure. In addition to 
binding the RNA loop, the β-hairpin (β’β”) of the RRM inserts into the major groove of the stem (Figure 3D) 
contacting the phosphate backbone of both strands with the side chains K315 and K316 (Figure 3E).  
 The mode of binding shows little sequence-specificity, although there are many intermolecular contacts 
(hydrophobic and hydrogen bonds) to both the bases and the sugar-phosphate backbone. All the phosphate 
groups between A12 and C15 are contacted by the short flexible C-terminal tail of the RRM that folds into a 
single helical turn and together with the structured regions, make up the core RRM. Using this tail, A12, U13, U14 
and C15 phosphate oxygen are involved in hydrogen bonding by N376, R372 and R371 side chains and A373 
main chain (Figure 3F), thus sandwiching the RNA on the Esheet surface. The bases of A12 U13, U14 and C15 
show stacking interactions and a limited number of hydrogen bonds. A12 interacts with Y325 and the edge of 
E(Figure 3G) U13 stacks between R328 and K334, with hydrogen bonds to R328 and T326 main chains  
(Figure 3H), U14 stacks between F288 and R372 with hydrogen bonds to T370 (Figure 3I) and C15 stacks 
between T286, N284 and R371 with hydrogen bonds to N285 and D283 main chains (Figure 3J). Many of 
these hydrogen bonds are not highly sequence-specific, involving the O2 carbonyl group of all three 
pyrimidines, which cannot discriminate cytosines and uracils. Altogether, the structure suggests that the RRM 
binds a NYNY single-stranded quartet (where Y is a C or U and N any nucleotide A,C,G,U).  
Although the main RNA binding surface in FUS is located on the RRME-sheet surface, the path of the 
RNA is very atypical. In a canonical mode of RNA binding by RRMs, the single-stranded nucleotides are spread 
on the surface of the E-sheet like rings on fingers, so that each base (ring) interacts predominantly with one E-
strand (finger), the nucleotides one to four interacting with E4, E1, E3 and E2, respectively, across the E-sheet 
(Maris et al., 2005).  Here, the four nucleotides bound by FUS RRM form a tight curve encircling T338 and 
7 
 
N323 with A12, U13, U14 and C15 bound in individual pockets (Figure 3D). Loop residues A12 and U13 bind near 
the end of β2, while U14 and C15 bind over β1 with no bases interacting with E3. Whereas in canonical RRMs, 
two aromatics in E1 and E3 stack with RNA bases and a third aromatic from E3 inserts between the two sugars, 
here the only canonical aromatic in E1 (F288) stacks with U14 and Y325 (from E2) inserts between the sugars of 
U13 and U14 (Figure 3H). The base of C15 interacts with the N-terminal region of E1, stacking with T286 
(Figure 3J). Overall, the binding topology of the single-stranded RNA over the E-sheet of the RRM is 
unprecedented and reflects the lack of the two aromatic side chains, which are commonly found on E3 of an 
RRM.  
The canonical E-sheet surface of FUS-RRM is supplemented in the FET family by a β-hairpin between 
α1 and β2 (β’β”), which extends the RNA binding surface. In our structure, this β-hairpin inserts into the major 
groove of the RNA stem with three side chains (N314, K315 and K316) interacting with three phosphate 
oxygens of the stem (Figure 3E, Figure S3D). The same structural feature and residues are present in the RRM 
of TAF15 and EWS, suggesting that this mode of RNA recognition is likely to be conserved throughout the FET 
family. The most C-terminal residue in this construct R377, represents the start of the RGG2 region and its 
position suggests that RGG2 may have further interactions with the stem-loop. 
Role of FUS RGG2 in RNA interactions  
To investigate the role of RGG2, we included 3 RGG repeats (RGGx3 378-390) C-terminal to the RRM and for 
which resonances could be assigned. The addition of these residues led to a large increase in affinity with the 
Kdapp of 13.9 PM compared to 84 PM along with a large increase in binding enthalpy. In contrast, addition of ten 
N-terminal residues (260-269) shows only a marginal increase in affinity (Figure 4A, Table S3). This effect is 
observed for two different stem-loops, but not for binding to short single-stranded RNA (Table S3 and data not 
shown). When monitoring the RNA resonances of two stem-loop RNAs we observe additional chemical shift 
changes indicative of an unfolding of the bases of the nucleotides in the 5’ part of the loop with RRM-RGGx3 
(260-390) compared to RRM (280-377) (Figure 5A, Figure S4A). This suggests that the RGG repeats in the 
presence of the RRM can remodel the RNA structure.   
Characteristic intermolecular NOEs and backbone chemical shift perturbations of the RRM-RGGx3:SL 
RNA complex show that the RRM binds RNA in a similar manner to the core RRM construct at the AUUC in 
the 3’ loop region of the stem-loop (Figure 5B black labels, Figure S4B). In addition, intermolecular NOE 
involving the RGG repeats are detected (Figure 5B red labels). Surprisingly, the RGG region shows little 
chemical shift perturbation in the backbone amide resonances on binding RNA despite the large contribution to 
binding affinity. Heteronuclear NOE analysis indicates that the RGGx3 is locally flexible with modest decrease 
in re-orientational motions when bound to an RNA stem-loop (Figure S4C). This is consistent with 
intermolecular NOEs detected from arginine and glycine residues of RGG2 showing multiple points of contact 
to the RNA (Figure 5B red labels). To obtain insights into this interaction, we used restraints from the core 
RRM-SL complex combined with several RGG-RNA intermolecular NOEs to model the complex. The resulting 
models suggest how the RGG repeats interact with the 5’ side of the loop and the minor groove of the stem 
(Figure 5C, Figure S4D). As such, the stem-loop:RRM structure provides a platform for interactions with RGG 
motifs. 
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To test the significance of shape recognition of FUS-RRM:SL complex, we measured binding affinities 
of a series of protein mutants of RRM-RGGx3 (Table S3, Figure 4B). R371A,R372A resulted in a 3 fold 
decrease in binding affinity confirming a contribution to the loop recognition and K315A,K316A to a 2 to 3-fold 
decrease confirming a contribution for binding the stem major groove. In contrast, mutation of residues arising 
from the opposite face of the β’-β” hairpin (N314A,Q319A,M321A) showed little effect. Mutation of both the 
β-sheet surface and the β’-β” hairpin (F288A/Y325A/K315A/K316A) gave a further 4 to 5-fold binding 
decrease. Introducing the same four mutations in the core RRM (residues 269-377) alone resulted in no 
detectable binding (Figure 4B). Comparing binding affinities of the core RRM (Kdapp 85 µM) with the RRM-
RGGx3 F288A/Y325A/K315A/K316A mutant (Kdapp 45µM) suggests synergistic binding by the RRM and the 
RGG motifs in good agreement with our NMR based model and recent binding studies with a promoter 
associated noncoding RNA sequence (Ozdilek et al., 2017). 
On further analysis, we identified additional weak intermolecular NOEs consistent with an additional 
binding of the RRM binds to the three nucleotides upstream of the main binding site: U8, A9 and C10 (Figure 5B 
blue labels). An additional binding event is consistent with the change in stoichiometry that we observe in our 
ITC measurements changing from 1 to ~1.5 with RRM-RGGx3 (Figure 4, Table S3) with the latter 
measurements representing a mixture of 1:1 and 1:2 RNA:protein complexes as depicted in Figure 5D. Similar 
results were obtained when binding the SON stem-loop (Figure S4). Overall, we propose a mechanism for FUS 
binding by which the RRM binds NYNY at the 3’ side of loop and the major groove of the stem, and RGGx3 
dynamically interacts with and unfolds the 5’ side of the loop. In our samples unfolding of the 5’ loop enables 
another molecule of FUS to partially bind (Figure 5D), but in a cellular environment, this unfolding of the loop 
could enable binding of additional proteins to the RNA. As such, we speculate that the proposed UA motif at the 
5’ side of the loop (Hoell et al., 2011) may originate from the binding of an unknown sequence-specific RNA 
binding protein. Further investigations would be required to identify this protein.  
FUS can bind a YNY stem-loop-GGK bipartite motif in vivo 
We then asked whether FUS recognizes bi-partite RNA elements in vivo. Using our structure-derived 
RNA motifs, we searched in CLIP data sets for FUS for the presence of stem-loops containing a YNY motifs 
(Y=C/U, N=A/C/G/U) at the 3’end of a stem-loop that is followed by a GGK motif (K=U/G) within a 30-
nucleotide distance (Figure 6A). We searched FUS CLIP-seq in HeLa cells (Zhou et al., 2013), PAR-CLIP in 
HEK293 cells (Hoell et al., 2011) and CLIP-seq in human brain and mouse neurons differentiated from 
embryonic stem cells (Lagier-Tourenne et al., 2012; Nakaya et al., 2013). We found in all datasets a small but 
significant increase of these motifs within FUS CLIP tags compared to control in which the sequences were 
randomized maintaining original nucleotide composition (Figure 6B), suggesting that FUS could recognize 
such a bipartite motif in vivo as well as in vitro (Figure S5A).  
RNA binding by FUS ZnF is crucial to splicing whereas binding by the RRM is less critical 
FUS widely regulates alternative splicing, including pre-mRNA with long introns and its own 
transcript via intron retention leading to nonsense mediated decay (Lagier-Tourenne et al., 2012; Zhou et al., 
2013). It was recently shown that FUS regulates minor intron splicing and that loss of FUS and its binding 
partner U11 snRNP from the nucleus could contribute to pathological mechanisms in ALS (Reber et al., 2016). 
We therefore tested the functional role of RNA binding by the RRM and the ZnF in splicing assays, including 
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minor intron excision from a skeletal-muscle sodium-channel (SCN4) which is stimulated by FUS, the 
autoregulation of FUS mRNA and the cross regulation of TAF15 mRNA. We therefore used mutants affecting 
RNA binding of the RRM (F288A, Y325A, K315A and K316A) and the ZnF (F438A, R441A, N435A, Figure 
6C).  These mutations reduced binding but retain the native fold of the RRM and the ZnF (Figure S5 B-C).  
FUS knockdown induced deficiency in the splicing of the SCN4A minigene in HeLa cells, which could 
be rescued by ectopic expression of wild type FUS, but not by FUS in which both the RRM and the ZnF were 
simultaneously mutated (Figure 6D). This demonstrates that both domains are essential for the role of FUS in 
minor intron splicing stimulation. Next, we tested the contribution of the individual domains. Mutants in the 
RRM alone had little effect, whereas mutations in the ZnF had an intermediate effect on splicing, suggesting 
that the ZnF has a dominant role, but that the RRM and ZnF act synergistically in promoting excision of the 
intron. Importantly, these differences in splicing activity do not arise from different knockdown efficiencies, as 
all samples have a comparable knockdown of endogenous FUS ranging from 1-3% (Figure S5D) and neither 
from differences in ectopic expression, as there is no significant difference between the expression levels of 
FUS wild type and mutants (Figure S5E).  
Next, we analyzed the effect of RNA binding by the RRM and the ZnF on the autoregulation of FUS 
and cross regulation of TAF15 mRNA (Figure 6E-F). Ectopic expression of FUS in HeLa cells resulted in a 
modest reduction in endogenous FUS mRNA. This effect was not observed with FUS carrying mutations in the 
ZnF (Figure 6E). To measure cross regulation of TAF15 mRNA, FUS knock out cells were used. Knockout of 
FUS in HeLa cells shows increased levels of TAF15 mRNA and ectopic expression of wild type FUS can 
efficiently restore repression (Figure 6F). FUS with the mutated ZnF can no longer repress TAF15. In contrast, 
the mutated RRM has little effect and mutation of both domains has an intermediate effect, suggesting that the 
RRM and ZnF might not act synergistically for this intron retention event (Figure 6F). In both assays, the 
mRNA level changes are unlikely to arise from differences in overexpression efficiencies, since no significant 
differences between exogenous FUS levels were detected in any case except between wild-type FUS and the 
double mutant in the endogenous FUS mRNA level assay. (Figure S6F and G). Together, these experiments 
show that the RNA interaction by the globular domains of FUS are important for FUS function in post-
transcriptional regulation of gene expression. 
 
Discussion 
The ZnF provides sequence-specificity to FUS 
We have elucidated how FUS ZnF is bound to UGGU. The two central guanines are deeply buried in 
sequence-specific pockets while U4 is recognized by side chains that could also accommodate a G, and U1 is not 
sequence-specifically recognized. The consensus sequence bound by FUS ZnF is NGGK. Conservation of 
structure and side chains within EWS and TAF15 indicate that this mode of recognition is conserved within this 
family (Figure 2G).  
RanB2 zinc fingers are a small family of zinc fingers with small ribbon-like domains consisting of two 
crossed E-hairpins and a subset of these domains bind RNA (Nguyen et al., 2011). The only structural data 
available of this ZnF family in complex with RNA comes from ZnF2 of the alternative splicing factor ZRANB2 
(Loughlin et al., 2009), which contains a central WARR motif that binds a GGU motif. Despite two changes 
10 
 
from Trp to Phe and Arg to Trp, FUS-ZnF binds the central GGU in a very similar manner (Figure 7A). 
Stacking of G2 and G3 with a Phe (rather than a Trp) by FUS ZnF enables direct hydrogen bonds between G2, 
rather than water mediated hydrogen bonds as observed with ZRANB2 (Figure 7B). The Trp replacing Arg 
conserved one hydrogen-bond to G2 and introduced stacking with the U1 base. In the FUS complex, additional 
residues Q420 to R422 are present and fold upon RNA binding, expanding the interface to envelop G2. TAF15 
ZnF possesses a Phe-Ala-Arg-Arg motif thus combining residues from both FUS and ZRANB2. Thus, despite 
an adjustment of some hydrogen bonds, the principle of RNA recognition of GGU in this family of ZnF is 
conserved. 
A GGU recognition motif has been detected in several CLIP experiments (Ishigaki et al., 2012; Lagier-
Tourenne et al., 2012). Our solution structure of FUS ZnF bound to RNA and our numerous binding studies 
with various RNA sequences clearly shows, that the ZnF of FUS is responsible for binding this motif. It is also 
notable that a GGUA motif has been identified in both, the TAF15 CLIP dataset (Kapeli et al., 2016) as well as 
with the in vitro method RNA compete (Ray et al., 2013), confirming that the sequence-specificity mediated by 
ZnF extends to the FET family in vivo. Finally, our splicing assays clearly show that the FUS-ZnF is 
functionally essential for its role in post-transcription gene regulation (Figure 6).  
The FUS RRM binds stem-loop RNAs in an unusual manner and with highly degenerate specificity 
The structure of the FUS RRM bound to the stem-loop RNA of hnRNPA2/B1 pre-mRNA reveals three 
individual binding pockets on theE-sheet surface as expected for an RRM (Figure 3). However, the path taken 
by these nucleotides is unusual with the three nucleotides form a tight turn rather than a straight line. Most 
contacts are of non-sequence-specific nature, with hydrophobic interactions and contacts to the phosphate 
backbone. The hydrogen bonds to the bases suggest a highly degenerate sequence specificity for a NYNY 
quartet. The tight turn in the path of the RNA upon binding to the RRM could predispose FUS-RRM to binding 
stem-loop RNAs since the RNA would be pre-formed in such a conformation. In addition, the contact in the 
major groove of the RNA stem by the β-hairpin (β’β”) -unique to the RRM of the FET family, further 
contributes to the recognition of such structures. The RNA recognition by the RRM is therefore more shape-
specific than sequence-specific.  
Only few RRMs show specific binding to stem-loops and among them are four structures with a single 
RRM bound to RNA, namely U1-A, U2-B’’, RBMY and U1-70K (Kondo et al., 2015; Oubridge et al., 1994; 
Price et al., 1998; Skrisovska et al., 2007). Compared to these complexes, the way FUS RRM binds to the stem-
loop RNA is markedly different (Figure 7 C-F). The most obvious difference is on the position of the RNA 
stem relative the RRM, which is rotated 180 degrees from U1-70K and 90 degrees with respect to the others 
(Figure 7 D-F). This originates primarily from interaction of the β-hairpin (β’β”) with the RNA stem in FUS 
RRM, whereas in the other proteins the interaction with the stem is mediated by the EE loop.  
FUS-RRM does not exclusively bind stem-loop structures. When testing various single-stranded 
sequences like AU-repeats or GC-repeats, chemical shift changes showed that the RRM remained the primary 
RNA binding domain. This is in agreement with the very degenerated binding consensus sequence that we 
deciphered from the structure. The RRM interaction with single stranded RNAs does possess an inherent 
sequence preference as shown by comparing affinity of ACGCGC (Kd 27 μM) and AAUAAA (Kd 120 µM, 
Table S3), with an exact definition of the RRM-RNA specificity requiring further investigation.  
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Role of the disordered RGG-rich interdomain linker in RNA binding 
RGG boxes are intrinsically disordered regions which are prevalent in RNA binding proteins. They are 
generally assumed to bind RNA through non-specific charge interactions or specifically bind and stabilize G 
quadruplexes, on which they could fold upon binding (Phan et al., 2011; Vasilyev et al., 2015). They are also 
known to be able to melt nucleic acids structure (Thandapani et al., 2013). For FUS, we observed a dynamic, 
“fuzzy” interaction between the RGG repeat and RNA. The RGG repeat does not adopt an ordered fold but 
destabilize an RNA structure - the stacked 5’ end of the loop (Figure 5). Despite remaining disordered, the 
RGG repeat greatly increases FUS RNA binding affinity and could promote the binding of another protein. We 
speculate that the UA-Y motif identified by PAR-CLIP (Hoell et al., 2011) could then originate from the 
binding of an unknown partner protein and not from FUS itself. 
Positively charged tails are found to greatly enhance binding affinity to structured RNA, by folding and 
interacting with the stem (Amarasinghe et al., 2000; De Guzman et al., 1998). More recently, positively charged 
residues C-terminal to the Rbfox1 RRM  (Chen et al., 2016) were found to increase binding of the core RRM to 
pre-miR20b by interacting in the major groove of the stem (Figure 7G). In the case of Rbfox1, the C-terminal 
region destabilizes the stem. What we found with FUS is therefore reminiscent to what was seen with Rbfox1, 
except that the FUS RGG interaction might also be crucial for recruiting additional proteins. 
RNA recognition has been traditionally thought to be achieved by globular proteins and domains. In 
contrast, genome-wide studies capturing all RNA binding proteins in the cells (Castello et al., 2012) have found 
a surprisingly large enrichment in intrinsically disordered regions (IDRs). Our work shows how the intrinsically 
disordered RGG repeats in FUS could enhance RNA binding affinity, and contribute to the re-modelling of 
RNA structure without adopting an ordered conformation. Conversely, it has been shown that RNA forms less 
ordered structures in vivo compared to in vitro, largely thought to be due to the presence of RNA binding 
proteins (Spitale et al., 2015). Intrinsically disordered RNA binding regions, such as RGG motifs, could 
contribute to this both by directly binding RNA and also by destabilizing RNA structure enabling additional 
folded RNA binding domains to bind. It will be interesting to see whether this is a widespread mode of 
interaction by RGG-rich intrinsically disordered regions of RBPs.  
Synergistic RNA binding by the multiple domains of FUS 
We have shown how the individual domains of FUS can each bind RNA and with which specificity. 
Do these domains bind RNA synergistically or independently? Chemical shift mapping of FUS RRM-RGG2-
ZnF (Figure 1B and Figure S1E) show that both the RRM and the ZnF domains can bind RNAs containing a 
stem-loop and a GGU motif. EMSA also indicates improved binding compared to the individual domains, 
prtenitally reflecting the active contribution of RGG2 (Figure S5A). Mutational analysis shows that RNA 
binding by the RRM and ZnF do act synergistically in splicing of SCN4 minigene whereas no synergistic effect 
was observed in regulation of FUS and TAF15 mRNA levels suggesting this effect could be context dependent. 
SHAPE-Map and ex-vivo SHAPE analysis of Xist long non coding RNA cross referenced with CLIP data 
mapped direct FUS binding sites to regions of single-stranded RNA surrounded by structured RNA (Smola et 
al., 2016), with some of the sites including stem-loops adjacent to a GGU motif. Interestingly, this region of 
Xist was shown to undergo changes in RNA structure in vivo compared to ex vivo, consistent with our proposal 
that FUS can remodel RNA structures.  
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Finally, RNA binding by FUS is important in facilitating efficient liquid-liquid phase separation into 
membrane less compartments like liquid droplets (Burke et al., 2015), the aging of which could lead to 
aggregation of FUS in ALS and FTLD patients (Patel et al., 2015). The modular nature of FUS RNA binding 
and the weak RNA binding affinity of the folded domains shown here are perfectly consistent with the weak 
multivalent interactions known to facilitate phase transition (Li et al., 2012). This multivalent RNA binding, 
together with the disordered regions of FUS, are well suited to play a role in the formation of the different 
phases and the RRM and ZnF have recently been shown to contribute to RNA mediated phase separation of 
FUS (Maharana et al 2018) . Furthermore, the role of RGG regions in destabilizing structured regions of RNA 
in addition to direct binding may further facilitate this process. The importance and relative roles of the different 
RNA binding domains in this process remain to be explored. 
In conclusion, we deciphered the first structural basis for RNA recognition by FUS. This provides an 
important step towards understanding in more detail the role of RNA in both FUS loss of function and toxic 
gain of function mechanisms in order to shed light on the role of FUS in ALS and FTLD pathology.  
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Main Figure Title and Legends 
Figure 1. Mapping RNA binding sites in FUS RRM-RGG2-ZnF.  
A) Domain composition of FUS (left) and sequence of RRM-RGG2-ZnF (right). B) Combined chemical shift 
perturbations of RRM-RGG2-ZnF on binding to an RNA stem loop from SON pre-mRNA (purple), ACGCGC 
(green), AUUAUUAUUAUU (orange), UGGUA (yellow) and part of SON containing a stem-loop and a GGU 
sequence downstream. C) Inserts of overlaid 1H-15N-HSQC spectra showing chemical shift perturbations of 
individual cross-peaks from representative backbone amides and one side-chain (N284) of FUS in their free 
(grey) and RNA bound state (colored similarly to panel B). See also Figure S1. 
Figure 2. Structure of FUS ZnF bound to UGGUG.  
A) 1H-15N-HSQC of FUS ZnF free (red) and bound to UGGUG (blue). B) Section of 13C-filtered 2D NOESY 
showing intermolecular NOEs between resonances of FUS Trp 440 and Phe 438 and RNA resonances. C) 
Superimposition of the 20 conformers forming the final NMR ensemble. D) Surface representation FUS ZnF 
(grey) bound to the RNA. E) Intermolecular contacts between FUS ZnF and U1 and G2. F) Same as E for G3 and 
U4. G) Sequence alignments of the ZnF of the three members of the FET protein family: FUS, EWS and TAF15. 
Boxed show the residues interacting with the RNA. See also Figure S2 and Table S1. 
Figure 3. Structure of RRM bound to stem-loop RNA from hnRNPA2/B1. 
A) 1H-15N-HSQC of FUS RRM (280-377) free (red) and bound to the RNA stem-loop of hnRNP A2/B1 pre-
mRNA (blue). B) Combined chemical shift perturbation. C) Overlay of the structural ensemble. D) Structure of 
the complex with the RRM ribbon shown in blue, the C-terminal tail in red and the RNA in yellow. Details of 
the RNA recognition by two extensions of the RRM core: (E) E’E”hairpin of the α1-β2 loop and (F) the C-
terminal helix. (G,H, I, J) Details of the intermolecular contact in the binding pockets for four RNA nucleotides 
on the RRM β-sheet: A12, U13, U14, C15. See also Figure S3 and Table S2. 
Figure 4. Binding affinities of RRM constructs and mutants with RNA. 
A) ITC measurements of several RRM constructs and hnRNPA2/B1 stem-loop RNA. B) ITC measurements of 
RRM-RGGx3 and one RRM mutants with hnRNPA2/B1 stem-loop. C) ITC measurements of RRM-RGGx3 
constructs with RNA stem-loop from hnRNPA2/B1, SON and short ssRNA ACGCGC and AAUAAA. See also 
Table S3 
Figure 5. Effect of RGG repeats on RNA binding by RRM. A) 1H-1H 2D TOCSY showing pyrimidine H5-
H6 correlation of the RNA stem-loops free (red) and in complex with RRM (blue) with combined chemical 
shifts mapped onto the RNA sequence. B) 3D 13C-filtered, 13C-edited NOESY of RRMRGGx3 (260-390) with the 
RNA stem-loop of hnRNPA2/B1 showing intermolecular NOEs in common with the core RRM:stem-loop, and 
additional NOEs (blue). C) Model of RRMRGGx3 (280-390) and the RNA stem-loop of hnRNPA2/B1. D) 
Proposed schematic model of the RRM binding to RNA stem-loops and role of the RGG2. See also Figure S4 
Figure 6. Functional role of the Bi-partite RNA motif present in FUS.  
A) The structure of the motif investigated and its enrichment in FUS-associated regions of public datasets. The 
motif is composed of a stem loop structure with a YNY tri-nucleotide (Y=C/U, N=A/C/G/U) at the 3’ end of the 
loop in combination with a GGK (K=G/U) sequence within 30 bp from the loop. B) The enrichment for this 
motif has been evaluated in several FUS CLIP studies to address whether it could play a functional role for FUS 
binding in vivo. As a control, these sequences have been randomised, maintaining the original nucleotide 
composition. In all studies, we could determine a significant (p -16), albeit limited, enrichment for the motif, 
suggesting a possible functional role. C) Schematic of FUS protein showing the mutations used in this study. D) 
Splicing of SCN4 minigene: Schematic representation of the SCN4A minigene (top). RT-qPCR results 
indicating the ratio of spliced to unspliced mRNA under control knockdown, FUS knockdown and FUS 
knockdown rescued with RNAi-resistant cDNA expressing various constructs (upper panel). Example 
immunoblots of FUS protein levels under control knockdown (lane 1), FUS knockdown (lane 2) and different 
FUS-FLAG rescue conditions (lanes 3-6) analyzed by western blot. HeLa cell extracts were subjected to SDS-
PAGE and western blotting with anti-FUS (upper row) and anti-FLAG (middle row). TyrTub (lower row) was 
used as loading control (lower panel). E) FUS mRNA levels: RT-qPCR results indicating the relative 
endogenous FUS mRNA levels normalized to five housekeeping genes upon different FUS overexpression 
conditions (upper panel). Example immunoblots showing similar overexpression levels of the different 
constructs (lower panel). F) Same as E for TAF15 mRNA. See also Figure S5 
 
Figure 7. Structural comparison of FUS RNA complexes. 
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A) Comparison between ZnF of FUS and ZnF2 of ZRANB2 bound to RNA showing placement of NGGU and 
B) Direct and water mediated hydrogen bonding of G2. C-G) RRM domains bound to stem loop RNAs. C) FUS 
RRM bound to stem-loop from hnRNPPA2/B1, D) U1A RRM bound to U1 snRNA stem-loop II (PDB 1URN). 
E) RBMY RRM bound to SELEX derived stem-loop (PDB 2FY1). F) U170K RRM bound to U1 snRNA stem-
loop I (PDB 4PKD). G) RbFox1 RRM bound to GCAUG motif in pre-miR 20b RNA showing interaction of the 
C-terminal linker with the RNA stem.  
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Table 1. FUS NMR Ensemble Statistics 
  ZnF:UGGUG  RRM:hnRNPA2/B1  
NMR Restraints     
Distance Restraints  794  2955 
Protein intramolecular 668  2596 
   intraresidual 152  517 
   sequential (|i-j|=1) 180  575 
   medium range (1<|i-j|<5 131  509 
   long range (|i-j|>=5 199  927 
   hydrogen bondsa 6  30 
  RNA intramolecular 52  324 
   intraresidual 43  203 
   sequential (|i-j|=1) 9  103 
   medium range (1<|i-j|<5) 0  0 
   long range (|i-j|>=5) 0  4 
   hydrogen bondsa 0  14 
  Complex intermolecular 74  73 
   long range (|i-j|>=5 68  70 
   hydrogen bondsa 6  3 
Torsion Anglesb  25   
Protein   backbone 20  140 
RNA   sugar pucker (DELTA) 5  40 
   Backbone A form stem -  88 
     
Energy Statisticsc     
  Average distance constraint violations    
    0.3-0.4 Å  0.5 +/- 0.5  4.8 +/- 2.0 
    >0.4 Å  0.0 +/- 0.0  1.1 +/- 1.4 
    Maximal (A)  0.30 +/- 0.05  0.44 +/- 0.08 
  Average angle constraint violations    
    <5 degree  0.4 +/- 0.6  4.2 +/- 1.5 
    >5 degree  0.0 +/- 0.0  0.2 +/- 0.4 
    Maximal (degree)  0.19 +/- 0.33  2.54 +/- 3.71 
  Mean AMBER Violation Energy    
    Constraint (kcal mol-1) 18.5 +/-1.9  109.0 +/-9.1 
    Distance (kcal mol-1) 18.5 +/-1.9  108.2 +/-8.4 
    Torsion (kcal mol-1) 0.0 +/-0.0  0.8 +/-1.3 
  Mean AMBER Energy (kcal mol-1) -3074.2 +/- 4.7  -7424.5 +/- 17.7 
  Mean Deviation from ideal covalent geometry    
    Bond Length (A)  0.0044 +/- 0.0001  0.0041 +/- 0.0000 
    Bond Angle (degrees) 1.357 +/- 0.016  1.438 +/- 0.011 
Ramachandran plot Statisticsc,d,e    
  Residues in most favoured regions (%) 85.5 +/- 2.1  85.7 +/- 1.5 
  Residues in additionally allowed regions (%) 14.5 +/- 2.1  13.5 +/- 1.2 
  Residues in generously allowed regions (%) 0.0 +/- 0.0  0.0 +/- 0.0 
  Residues in disallowed regions (%)  0.0 +/- 0.0   
RMSD to mean structure Statisticsc,d    
  Protein    
    Backbone atoms 0.23 +/- 0.08  0.23 +/- 0.06 
    Heavy atoms 0.41 +/- 0.08  0.54 +/- 0.08 
  RNA     
    Backbone atoms 0.79 +/- 0.25  0.72 +/- 0.21 
    Heavy atoms 0.71 +/- 0.22  0.74 +/- 0.22 
  Complex    
    Backbone atoms 0.52 +/- 0.15  0.90 +/- 0.38 
    Heavy atoms 0.55 +/- 0.10  0.99 +/- 0.35 
     
     
a Hydrogen bond constraints were identified from slow exchanging amide and imino protons in D2O  
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b Torsion angle based on HNHA (ZnF) or TALOS+ (RRM); sugar puckers based on homonuclear 
TOCSY and DQF-COSY; RNA backbone constraints in A form stem (RNA stem-loop) 
c ZnF:UGGUG  ZnF : 422-453, Chain ID: A (Sequence Range: 418-454); RNA : 1-4, Chain ID: B 
(Sequence Range: 1-5) 
d RRM:hnRNPA2/B1 stem-loop RNA RRM : 284-372, Chain ID: B (Sequence Range: 276-377) 
  RNA : 4-20, Chain ID: A (Sequence Range: 1-23) 
e Ramachandran plot, as defined by the program Procheck (Laskowski et al., J.  
 Biomol. NMR 8, 477-486, 1996) 
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STAR Methods 
CONTACT FOR REAGENT AND RESOURCE SHARING 
“Further information and requests for resources and reagents should be directed to and will be fulfilled by the 
Lead Contact, Frederic Allain (allain@mol.biol.ethz.ch) 
METHOD DETAILS 
Expression and Purification FUS 
RRM, RRM-RGG-ZnF, RRMRGGx3 and Zinc Finger subcloning. 
DNA fragments encoding RRM, RRM-RGG3 and RRM-RGG2-ZnF were subcloned using NdeI and XhoI 
restriction sites into pET28a plasmid which had been modified to include to TEV restriction site. DNA 
fragments encoding FUS ZnF were subcloned into pGEX6P-1 using BamHI  and EcoRI. 
Zinc Finger protein expression and purification: 
ZnF fragments transformed into BL21 codon-plus cells (RIL) and expressed in M9 minimal media 
supplemented with 15N ammonium chloride (1g/L) and or 13C glucose (1g/L) thiamine and trace elements in 
the presence of 50 µg/mL Carbenicillin and 34 µg/mL Chloramphenicol  Typically 2L of culture were grown at 
37 oC to log phase (OD600 0.6-0.8) then shifted to 25oC, media was supplemented with zinc chloride to 0.1mM 
expression was induced with isopropyl b-D-1-thiogalactopyranoside to 0.5mM overnight. Cell were harvested 
by centrifugation and resuspended in lysis buffer of 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM β-
mercaptoethanol, 0.5% Triton X-100, 5 mM MgCl2, 0.1 mM ZnCl2 supplemented with 10 mg Lysozyme and 
Complete-EDTA-Free Protease inhibitor (Roche). Cell were lysed by two freeze thaw cycles, the addition of 
DNase I at room temperature, followed by sonication. Lysate was clarified by centrifugation at 38,000 x g. 
The clarified lysate was loaded onto glutathione-Sepharose 4B beads (GE Healthcare) pre-equilibrated with the 
lysis buffer for 30 minutes at 4oC. Beads were washed with 50 mM Tris-HCl (pH 8), 300mM NaCl, 10% 
Glycerol 1mM β-mercaptoethanol and eluted with 50 mM Tris-HCl (pH 8.0) 150mM NaCl 20 mM glutathione 
1mM β-mercaptoethanol. The fusion protein was dialysed into cleavage buffer at 4oC 50 mM Tris-Cl pH 7.0 at 
RT (7.5 at 4 oC) 150 mM NaCl, 1mM DTT, 0.001% Triton X-100 and cleaved with PreScission (purified in 
house) leaving 5 additional N terminal residues (GPLGS). Cleaved solution was adjusted to pH 8.0 and passed 
over glutathione-Sepharose 4B beads to removed cleaved GST tag and cleaved protein concentrated and further 
purified by size exclusion chromatography on a Sephadex 75 10/30 column (GE healthcare) in 50 mM HEPES 
pH 7.2, 150mM NaCl, 1 mM DTT, 5μM ZnCl2 and protein was concentrated and stored in this buffer. Final 
protein was analysed for nucleic acid contamination using A260nm/A280nm and concentration was estimated using 
A280nm using a theoretical extinction coefficient of  4523 M-1cm-1 and stored at -80 oC. Before use, ZnF protein 
was dialysed into NMR buffer 20 mM Na2HPO4/ NaH2PO4 ,1 mM β-mercaptoethanol, 5μM ZnCl2. 
RRM and RRM-RGG2-ZnF protein expression and purification: 
RRM and RRM-RGG2-ZnF constructs were expressed as per zinc finger in the presence of 50 µg/mL 
Kanamycin and 34 µg/mL Chloramphenicol. Protein expression was induced at OD600 0.6-0.8 with 1mM  with 
isopropyl b-D-1-thiogalactopyranoside at 22 oC overnight. Cell were harvested by centrifugation and 
resuspended in lysis buffer of 50 mM Na2HPO4/ NaH2PO4 pH 8, 1M NaCl, 2 mM β-mercaptoethanol, 0.5% 
Triton X-100, 0.1 mM ZnCl2 supplemented with 5 mM MgCl2 10 mg Lysozyme and Complete-EDTA-Free 
Protease inhibitor (Roche). Cell were lysed by two freeze thaw cycles, the addition of DNase I at room 
temperature, followed by sonication. Lysate was clarified by centrifugation at 38,000 x g.  
The clarified lysate was supplemented with imidazole to 5 mM then loaded onto Ni-NTA beads (QIAGEN) pre-
equilibrated with the lysis buffer. Beads were washed stepwise with 50 mM Na2HPO4/ NaH2PO4 pH 8, 1M 
NaCl, 1mM β-mercaptoethanol 20 mM imidazole, followed by 50 mM imidazole, then eluted with50 mM 
Na2HPO4/ NaH2PO4 pH 8, 1M NaCl, 1mM β-mercaptoethanol 300 mM imidazole. The fusion protein was 
dialysed into TEV cleavage buffer 50mM Tris-Cl pH 8.0 50mM NaCl 2 mM β-mercaptoethanol and cleaved 
with TEV (purified in house) at 4 oC overnight leaving 4 additional N terminal residues (GSHM). Cleaved 
solution was adjusted to 1M NaCl, 10 mM imidazole before and passing over Ni-NTA beads to remove His tag 
concentrated and stored at -80 oC.   
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Cleaved protein of RRM constructs were incubated with SuperaseIn RNase inhibitor (Ambion) and further 
purified by size exclusion chromatography on a Sephadex 75 10/30 column (GE healthcare)  in, 50 mM 
Na2HPO4/ NaH2PO4 pH 7, 150mM NaCl, 1 mM DTT.  Final protein purity was checked by SDS gels (Figure 
S6) and analyzed for nucleic acid contamination using A260nm/A280nm and concentration was estimated using 
A280nm by calculating with the theoretical extinction coefficient of  8480 M-1cm-1  (RRM, RRMRGG3) and 20970 
M-1cm-1 (RRM-RGG2-ZnF) and stored at -80 oC.  
Before use, proteins were dialyzed into NMR/ITC buffer: 
x RRM: 20 mM Na2HPO4/ NaH2PO4, 1 mM β-mercaptoethanol. 
x RRMRGGx3 : 20 mM Na2HPO4/ NaH2PO4, 40 mM NaCl, 1 mM β-mercaptoethanol. 
x RRM-RGG2-ZnF: 20 mM Na2HPO4/ NaH2PO4,,1 mM β-mercaptoethanol, 5μM ZnCl2. 
x ITC buffer (all samples): 20 mM Na2HPO4/ NaH2PO4, 40 mM NaCl, 1 mM β-mercaptoethanol. 
 
RNA preparation 
Short RNA oligonucleotide (Table S4) were purchased from Dharmacon and deprotected according to the 
manufacturer’s instructions, lyophilized and resuspended in water twice, before resuspending in D2O or the 
appropriate buffer.  
Longer RNAs were produced using in vitro RNA transcription (Table S4). Double stranded DNA templates 
were prepared by annealing two DNA oligonucleotides or cloning sequence of interest into pUC18 (stem-loop 
from hnRNPA2/B1) or pUC19 (stem-loop from SON) and linearized by cleavage with BbsI at 37 oC overnight. 
RNA was transcribed for 4 hours at 37 oC using with T7 RNA polymerase (purified in house) in 40 mM Tric-Cl 
pH 8.0 1 mM spermidine, 0.01% Triton-X, 5 mM DTT, with MgCl2 and rNTP concentrations optimized for 
each transcript and the reaction stopped by the addition of EDTA. For 15N-13C labelled RNA stem-loops 15N13C 
labelled rNTPs purified in house were used. Reaction mixtures were then purified on denaturing anion exchange 
HPLC (Duss et al., 2010) and isolated using butanol extraction (Cathala and Brunel, 1990), resuspended in H2O 
lyophilized. RNA pellets were then resuspended in 10 µM in H2O, heated for 5 minutes at 65 oC then snapped 
cooled in liquid nitrogen followed by lyophilization. RNA pellets were then resuspended in NMR buffer.  
Synthesized RNA oligonucleotides (Dharmacon) were deprotected in supplied deprotection buffer, 65 oC 60 
minutes. The sample was then diluted in water to 5 mL followed by lyophilization, repeated twice. RNA was 
resuspended in the appropriate NMR buffer, ITC buffer or D2O. 
NMR Spectroscopy: 
All NMR Spectroscopy measurements were performed using Bruker AVIII 500 MHz, AVIII 700 MHz and 
Avance 900 MHz spectrometers equipped with cryoprobes. The data were processed using Topspin 3.1 (Bruker) 
and analysed with Sparky (http://www.cgl.ucsf.edu/home/sparky/) and NMR-FAM-SPARKY (Lee et al., 2015). 
NMR titrations and complex preparation: 
NMR titrations of protein RNA complexes were performed by adding unlabeled concentrated RNA (1-5mM) to 
15N or 13C-15N labeled protein (0.2-1.5 mM) in NMR buffer (or vice versa) and protein monitored by 1H-15N-
HSQC, and RNA monitored by 1D and 1H-1H-TOCSY (tm 50 ms) at 303 K and 283 K. The ZnF:UGGUG 
complex was formed in a similar manner with an additional incubation step at 37 oC to facilitate binding. 
Sample measurements were then performed at 303 K, 283 K or 278 K. For complex formation of FUS-RRM, 
15N labelled protein was titrated into 15N13C hnRNPA2/B1 stem-loop to monitor chemical shift changes in sugar, 
base and imino resonances monitored by 1H- 13C-HSQC and 1H-15N-HSQCs. Sample was lyophilized before 
resuspending in D2O. Low salt buffers were required for RRM-RGG2-ZnF and ZnF 1H-15N HSQC titrations in 
order to avoid intermediate exchange of the ZnF resonances when bound to RNA. 
NMR measurements and assignments 
RRM-RGG2-ZnF free and in complex with RNAs 
Sequence specific backbone and side chain assignments of protein were achieved using a classical approach. All 
measurements were at 303 K unless otherwise indicated. Sequence specific backbone assignments of RRM-
RGG2-ZnF in free and bound to hnRNPA2-GGU RNA were achieved using 2D 1H-15N HSQC, 2D 1H-13C-
HSQC, 3D HNCA, 3D CBCACONH, 3D HNCACB, 3D HNCO, 3D HNCACO including 159 residues of 180 
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non proline residues (88%). The assignment of some stretches of sequential glycines in RGG2 was hampered 
due to overlap. Assignment of all other RNA bound forms RRM-RGG2-ZnF:RNA complexes were achieved by 
following peaks in NMR titrations. The heteronuclear 1H-15N values were measured employing water flip-back 
pulse. 
 
ZnF:UGGUG complex: 
Protein sequence specific backbone and side chain assignments of FUS-ZnF bound to UGGUG (13C-15N-
ZnF:unlabelledRNA 1:1.3)  were achieved using 3D HNCA, 3D H(C)CH-TOCSY (tm 25 ms) at 303 K and  3D 
1H-15N NOESY and 3D 1H-13C NOESY (tm 120 ms) and 2D NOESY at 303 K and 278 K. Intramolecular ZnF 
constraints FUS-ZnF bound to UGGUG ( ZnF:RNA 1:1.3) were taken from NOESY experiments at 303 K. 
Backbone PHI angles restraints were taken from 3D HNHA.  
RNA was assigned from 2D TOCSY (tm 25 and 50 ms), DQF-COSY, 2D NOESY (tm 120 ms), 
natural abundance 13C-HSQCs and 1H-31P COSY from a sample of 15N-ZnF:unlabeled UGGUG (ZnF: RNA 
ratio 1:0.9)  combined with a and 2D F2 filtered NOESY (tm 120 ms) with a sample of 15N-13C ZnF in complex 
with unlabeled RNA (1:1). Sugar puckers in the complex were identified from 2D 1H-1H- TOCSY (tm 25 ms) 
and DQF-COSY, syn or anti conformations were identified from NOE patterns of H6 or H8 resonances.  
Intermolecular NOEs were identified from 2D NOESY and 2D 13C F1 filtered, F2 filtered NOESY (Peterson et 
al., 2004) in D2O and 2D NOESY optimized for imino detection and 3D 15N-NOESY with 15N carrier frequency 
adjusted for Arg NE detection both at 278 K. Intermolecular hydrogen bond constraints were derived from 
protected imino resonances and preliminary structures. 
 
FUS RRM: RNAstem-loop hnRNPA2/B1 complex 
Protein sequence specific backbone and side chain assignments of  RRM (280-377): hnRNPA2/B1 RNA stem-
loop (13C-15N RRM:15N or unlabeled RNA 1:1.2) were achieved using 3D  HNCA, 3D H(C)CH-TOCSY and 3D 
(H)CCH-TOCSY (tm 25 ms) at 303 K. Intramolecular RRM constraints were incorporated from  3D 1H-15N 
NOESY and 3D 1H-13C NOESY (tm 120 ms) and 2D NOESY at 303 K. Protein dihedral backbone constraints 
derived from TALOS+ (Shen et al., 2009). 
Stem-loop RNA in free and RRM bound forms was assigned using 1H-13C HSQCs, DQF-COSY, 2D TOCSY 
(tm 25 and 50 ms), 3D (H)CCH-TOCSY and 3D 1H-13C NOESYs in D2O. Protected imino and amino 
resonances were assigned from 1H-15N- HSQCs 2D NOESY in H2O at 283K. RNA base pair constraints were 
derived from imino and amino resonances protected in D2O and cross-strand NOEs in RNA helical regions. 
Sugar puckers were identified by 2D TOCSY (tm 25ms) and confirmed by can1-can2 analysis of 13C sugar 
chemical shifts (Ebrahimi et al., 2001) and syn or anti conformations identified from NOE patterns of H6 or H8 
resonances. Intermolecular NOEs were identified in 2D F2 13C-filtered NOESY and 3D (F1 edited, F3 filtered) 
NOESY spectra with either the RRM 15N-13C labelled and RNA unlabeled or RRM 15N labelled and RNA 13C-
15N labelled and a 2D NOESY (tm 80ms) in D2O with 15N labelled RRM and unlabeled RNA. Detection and 
assignment of intermolecular NOEs were also confirmed and clarified using sample of RRM bound to 
hnRNPA2/B1 ΔA11 in which A11 was not present. This residue does not contact the protein and intermolecular 
protein-RNA contacts are conserved between the two complexes. 
 
FUS RRM-RGGx3: RNAstem-loop complexes 
Protein sequence specific backbone and side chain assignments of RRM (260-390) were achieved using 3D 
HNCA, CBCACONH, HNCA. HNCACO and HCCH-TOCSY. In complex with RNA stem-loops from 
hnRNPA2/B1 and SON, intermolecular NOEs were detected using 2D F2 13C-filtered NOESY and 3D (F1 
edited, F3 filtered) NOESY spectra in D2O. The heteronuclear {1H}-15N values were measured as proposed 
employing water flip-back pulse. 
 
Structure calculation and refinement 
The resonance assignments of each protein bound to RNA was used as input for automatic peak picking and 
NOESY assignment using ATNOS-CANDID (Herrmann et al., 2002). Resulting peak lists were checked and 
supplemented manually. RNA and intermolecular NOESY peaks were picked and assigned manually and 
calibrated from H5-H6 peaks of pyrimidines. Protein peaks were then re-assigned with NOEASSIGN module of 
CYANA 3.96 (Guntert and Buchner, 2015) and manually checked. 
For the ZnF:UGGUG complex, initial calculations were run in the absence of zinc ion. Once the zinc 
binding residues were identified from preliminary structures, loose SG-SG constraints were utilized. Automatic 
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NOE assignment was run for residues 425-454 keeping any annual assignments. Constraints from residues 418-
424 were then added in subsequent rounds of calculations in the presence of RNA. Intermolecular hydrogen 
bonds were identified from protected imino resonances and preliminary structure calculations and explicit 
intermolecular hydrogen bonds and zinc constraints were only added in final structure calculations and 
refinement. 
For the RRM:stem-loop complex initial complex calculations, unambiguous NOEs to the RRM were 
included positioning the nucleotides, followed by inclusion of intermolecular NOEs to the C-terminal extension. 
Intermolecular NOE with ambiguous assignments were then included as ambiguous restraints in CYANA and 
assigned based on preliminary calculations. A number of intermolecular NOEs from A12 incompatible with this 
structure were observed from RRM:hnRNPA2/B1 SL complex (listed in SI Table 2) in low salt buffer used in 
samples for structure determination. To further confirm the final intermolecular constraints, we used 
intermolecular NOEs from RRM: hnRNPA2/B1 stem-loop with A11 deleted which showed a single set of 
intermolecular NOEs.  These additional A12 intermolecular NOEs appear to be a subset of those detected in the 
RRMRGGx3:hnRNPA2/B1 complex which was interpreted as a second binding event as shown with ITC data.  
Final structure calculations in CYANA included intra protein, RNA and intermolecular NOEs, protein 
dihedral backbone constraints, intra protein hydrogen bond and RNA base pair constraints, sugar pucker and syn 
or anti conformations identified from NOE patterns of H6 or H8 resonances and for stem-loop RNAs. For 
ZnF:UGGUG complex zinc ion was included using a CYSZ residue. Of 500 structures, the 50 lowest energy 
structures were selected for refinement with SANDER module of AMBER12 (Case et al., 2005) using ff12SB 
force field with implicit solvent and 20 were selected.   
 
RRM-RGGx3:hnRNPA2/B1 stem-loop model: 
A model of RRM-RGGx3: hnRNPA2/B1 was calculated using intermolecular NOEs identified from RGG 
extension in combination with constraints from the core RRM:hnRNPA2/B1 stem-loop complex. Structures 
were calculated in CYANA and refined in Amber 12.  
 
 Isothermal Titration Calorimetry 
ITC experiments were performed on a VP-ITC microcalorimeter (Microcal). Protein and RNA were extensively 
dialyzed in ITC buffer 20 mM Na2HPO4/ NaH2PO4, 40 mM NaCl, 1 mM β-mercaptoethanol. RRM, RRM-RGG 
or ZnF (400-800 µM) was titrated into RNA (20-40 µM) using a single 2 µL followed by 12 µL injections every 
600 s at 30 oC with a stirring rate of 307 rpm. Raw data was integrated was analysed according to a’ single set of 
sites’ model in Origin 7.0. The data measured did not support reliable analysis as two independent sites. 
 
Band Shift Assays: 
Radiolabelled band shifts: Purified RNA from in vitro RNA transcription reactions were dephosphorylated 
Antarctic phosphastase (NEB), buffer exchanges then 5' end labelled with T4 polynucleotide kinase using (New 
England Biolabs) with γ-32P-ATP (5000Ci/mmol) according to the manufacturer’s instructions. Binding 
reactions were set up in a total volume of 30 μL and comprising of a constant concentration of 32P-labeled probe 
(0.1 pmole), increasing concentrations of protein, in a buffer consisting of 20 mM HEPES 7.9 50mM KCl 5mM 
MgCl2 5% Glycerol,0.03 mg mL-1 heparin. Binding reactions were setup on ice followed by an incubation at 4 
oC for 30 min after which 15 μL of each sample was loaded onto a pre- run 8% native polyacrylamide gel made 
up in 0.5 x Tris-Borate and electrophosed at 100 V for 1 hour, then dried and analysed using a PhosphorImager 
(Amersham Biosciences).  
Non radiolabelled band shifts: Binding reactions were setup in a similar manner except the RNA concentrations 
was 10 μM in a total volume was 20 μL of which 10 μL was loaded onto the gel. The RNA was visualized using 
0.1% toluidine blue.  
 
Searching for YNY motif in FUS CLIP datasets 
For this analysis, we made use of processed data as provided on the relative GEO page of each study. These data 
represent genomic intervals determined as putative FUS binding sites on the relative mRNA by peak calling 
procedures. These regions were converted to the latest human genome assembly hg38, using UCSC liftOver 
utility. The nucleotide sequence has been retrieved by querying the genome with Samtools (v1.2). The presence 
of hairpin loop in these sequences has been determined via RNAfold (v2.1.9), with local setup and no-lonely-
pairs option (RNALfold -noLP) in order to detect reliable stem structures instead of large scale secondary 
structures. The plot shows the percentage of regions in each study that contain at least one bipartite motif. This 
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quantity is influenced by many factors, most notably the average length of the peaks. For this reason, we 
compared and tested our results against a scrambled version of the nucleotide sequences as control. 
 
Minor Intron splicing assay  
The SCN4A minor intron splicing reporter assay with related RT-qPCR primers were described previously 
(Reber et al., 2016) and determination of endogenous FUS mRNA levels with related RT-qPCR primers are 
described in (Reber et al., 2018). Quantification of FUS protein levels were normalized against tubulin or 
polyclonal rabbit anti-actin (20-33) [Sigma, A 5060]. The pcDNA6F-FUS-GSG15-FLAG plasmid described in 
Reber et al., 2016 was used to create the vectors coding for the FUS RNA-binding mutants (mutRRM, mutZNF 
and mutRRM/ZNF respectively) with the QuickChange Lightning Multi Site-Directed Mutagenesis Kit 
(Agilent) using primers in Table S5. 
The SCN4A minor intron splicing reporter assay is done as follow. 2.5 x 105 HeLa cells, maintained in a 
humidified incubator at 37°C and 5% CO2, where seeded per well of a 6-well plate in DMEM+/+ (day 0; 
DMEM+/+: Dulbecco’s modified Eagle’s medium (DMEM, (ThermoFisher Scientific, 32500035)) supplemented 
with 10% fetal calf serum (FCS (Amimed, Bioconcept, 2-01F30-I)), penicillin (100 IU/mL), and streptomycin 
(100 μg/mL)). On day 1, the cells were co-transfected with 400 ng of the SCN4A reporter plasmid, 500 ng 
pSUPuro plasmid and 600-800 ng (to allow for equal expression) of the corresponding FUS rescue plasmid 
using Dogtor (OZ Biosciences, DT51000)) according to the manufacturer’s instructions. On day 2, the cells 
were split into a T25 flask and selection was started using 2 µg/ml puromycin (Santa Cruz Biotechnology: sc-
108071A. Puromycin selection was maintained until day 4. On day 5, half of the cells were harvested using 
Trizol for subsequent standard RNA isolation. The purified RNA was DNase treated using the TURBO DNA-
free™ Kit (ThermoFisher Scientific, AM1907) according to the manufacturer’s manual. Reverse transcription 
of total RNA was performed using the AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent 
Technologies, #200436) according to the manufacturer’s manual. RT-qPCR was performed using 3 µl cDNA, 1 
x MESA GREEN qPCR Mastermix Plus for SYBRR Assay No ROX (Eurogentec, 05-SY2X-03+NRWOU) and 
each 8 µl forward and reverse primer in a total volume of 15 µl per reaction. Samples were measured in 
duplicates in a Rotorgene6000 (Corbett). The following cycling conditions were used: 95°C, 5 min; 95°C, 15 s; 
60°C 1 min; 40 cycles. A melting curve was recorded from a temperature gradient from 65°C to 95°C, 5s/°C. 
Analysis was performed using the Rotor-Gene 6000 Series Software V1.7. The other half of the cells were re-
suspended in SDS-loading buffer for subsequent SDS-PAGE western blot analysis. Hereto, 1 x 105 cell 
equivalents were separated on a 8 % SDS-PAGE and transferred to a nitrocellulose membrane (Whatman, 
Optitran BA-S 85) using a TE77 ECL Semi-Dry Transfer Unit (Amersham Biosciences). Membranes were cut 
in two pieces and blocked with 5 % non-fat dry milk in 0.1 % Tween in TBS and subsequently incubated for 2 h 
at room temperature with the primary antibodies mouse anti-FLAG (Sigma-Aldrich, F1804), rabbit anti-FUS 
(homemade, (Raczynska et al, 2015)) or mouse anti-tyrosine tubulin (Sigma-Aldrich, T9028) and rabbit anti-
actin (Sigma, A 5060) respectively. Thereafter, the membranes were washed 5 x 5 minutes with 0.1 % Tween in 
TBS and subsequently incubated with the fluorescence-labelled secondary antibodies (IRDye® 800CW Goat 
anti-Rabbit IgG (H + L) (LI-COR, 925-32211) and IRDye® 680LT Goat anti-mouse IgG (H + L) (LI-COR, 
926-68020)) for 1.5 h at room temperature. The dried membranes were analysed with the Odyssey Infrared 
Imaging System (LI-COR). See Table S6 for qPCR primers. 
 
FUS and TAF15 mRNA regulation 
HeLa wild-type and FUS knockout cells were grown in DMEM-F12 (Life Technologies) with 10% FBS (Life 
Technologies) and 1% penicillin/streptomycin (Gibco). Transient plasmid transfections of pcDNA6F-FUS-
GSG15-FLAG plasmid with RRM/ZnF mutations were achieved using Lipofectamine®2000 Transfection 
Reagent (Life Technologies) according to manufacturer’s protocol with 1ng/µl DNA. Cells were harvested in 
Trizol for standard RNA extraction or RIPA buffer for immunoblot analysis. After RNA extraction, cDNA was 
prepared using SuperScript® III First-Strand Synthesis SuperMix (Life Technologies). qPCR was performed in 
duplicates from 6 biological replicates using FastStart Universal SYBR Green Master (Roche) and the primer 
sets (Table S5).  
qPCR data was analysed according to Vandesompele et al. (Vandesompele et al., 2002) with their provided 
excel macro tool. The statistical significance of two groups of results was determined by a two-tailed, paired t-
test and quantification graphs are displayed as mean ± SD. For protein analysis the concentration was adjusted 
based on BCA assay (Thermofisher) and lysates were boiled in loading buffer with reducing agent before 
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loading the samples on Bolt 12% Bis-Tris gels. Gels were transferred onto nitrocellulose membranes using iBlot 
2, which were blocked with 5 % non-fat skimmed powder milk in PBS-Tween and probed with primary 
antibodies ON (anti-FUS, Bethyl A300-293A, 1:10 000; anti-GAPDH, Abcam, 1:5000; anti-FLAG, FG4R, 
Thermofisher, 1:500) followed by secondary HRP-conjugated goat anti mouse or rabbit IgG antibodies (1:5000, 
1:10000, respectively Jackson Laboratories). Immunoreactivity was visualized by chemiluminescence (GE 
Healthcare). 
 
DATA AND SOFTWARE AVAILABILITY  
PDB deposition: 6GBM, 6G99 
BMRB deposition: 34258, 34259 
 
KEY RESOURCES TABLE 
 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit anti-FUS described in 
(Raczynska et al., 
2015) 
 
anti-Flag M2 antibody Sigma-Aldrich F1804 
mouse anti-tyrosine tubulin Sigma-Aldrich T9028 
   
Bacterial and Virus Strains  
Escherichia coli BL21(DE3) codon plus RIL  Stratagene  230240 
   
Chemicals, Peptides, and Recombinant Proteins 
   
Critical Commercial Assays 
QuikChange Lightning Multi Site-Directed Mutagenesis 
Kit  
Agilent 210515 
SuperScript® III First-Strand Synthesis SuperMix  Life Technologies 18080400 
 
   
Deposited Data 
ZnF:UGGUG PBD 6GBM 
RRM:RNA stem-loop PDB 6G99 
ZnF:UGGUG Chemical Shifts BMRB 34258 
RRM:RNA stem-loop Chemical Shifts BMRB 34259 
   
Experimental Models: Cell Lines 
FUS KO cells HeLa (Reber et al., 2016)  
   
Oligonucleotides 
Oligonucleotides used for structural studies see SI Table 
3 
This study  
Primers for mutation and mRNA levels see table 3 This study  
   
Recombinant DNA 
pET28a -TEV-RRM-RGG2-ZnF (269-454)  This study  
pET28a -TEV-RRM-RGG2-ZnF (280-454) This study  
pET28a -TEV-RRM (280-377) This study  
pET28a -TEV-RRM (269-377) This study  
pET28a -TEV-RRMRGGx3 (269-390) This study  
pET28a -TEV-RRM RGGx3 (260-390) This study  
pGEX6P-ZnF (422-454) This study  
pGEX-6P-ZnF (418-454) This study  
pET28a-RRM-RGG2-ZnF (269-454) 
F288A,K315A,K316A,Y325A, F348A, R441A, N445A 
This study  
pcDNA6F-FUS-GSG15-FLAG  (Reber et al., 2016)  
pcDNA6F-FUS-GSG15-FLAG 
F288A,K315A,K316A,Y325A, F348A, R441A, N445A 
This study  
SCN4 minigene (Raczynska et al., 
2015) 
 
Key Resource Table
   
Software and Algorithms 
Topspin 3.2 Bruker  
Sparky / NMR-FAM (Lee et al., 2015) https://nmrfam.wisc.
edu/software.htm 
Unio ATNOS CANDID (Herrmann et al., 
2002) 
 
CYANA 3.96 (Guntert and Buchner, 
2015) 
L. A Systems 
AMBER 12 (Case et al., 2005)  
PYMOL Schrodinger https://pymol.org/2/ 
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 Figure S1. Mapping RNA binding sites in FUS RRM-RGG2-ZnF related to Figure 1.  
Supplemental Text and Figures
A) 1H-15N Heteronuclear NOE free (upper) and bound to stem-loop of SON (lower). Reference (blue), NOE 
experiment (red-positive and yellow-negative). B-F) 1H-15N-HSQC of FUS RRM-RGG-ZnF free (red) and bound to 
RNA motifs (other color): B) Bound to stem-loops from SON (upper, purple) and hnRNPA2/B1 (lower, aqua) pre-
mRNAs. C) Bound to single-stranded RNA ACGCGC (upper, green) and AUUAUUAUUAUU (lower, orange), D) 
Bound to single stranded RNA UGGUA (upper, yellow) and DNA (lower) TCCCCGT (blue), AAAGTGTC (green), 
AGGTTCTA (yellow), E) Bound to stem-loop RNA with an extension containing a GGU motif (SL+GGU) from 
SON (upper, light blue), and from hnRNPA2/B1 pre-mRNA (lower, grey), F) (upper) Overlay of RRM-RGG2-ZnF 
bound to SON stem-loop (purple) and of the isolated RRM bound to the SON SL (black). (lower) Overlay of RRM-
RGG2-ZnF bound to UGGUA (yellow) and of the isolated ZnF bound UGGUA (red). G) Chemical shift difference 
between RRM-RGG2-ZnF bound to SON-GGU and SON (black) compared to the chemical shift perturbation of 
RRM-RGG2-ZnF on binding SON-GGU (blue). H) Chemical shift difference between RRM-RGG2-ZnF-SON SL and 
RRM:SON SL complexes (black) from overlay shown in F upper panel) compared to chemical shift perturbation of 
RRM-RGG2-ZnF binding to SON-SL RNA (purple, from spectra shown in B upper panel). I) Chemical shift 
differences between RRM-RGG2-ZnF:UGGUA and ZnF:UGGUA complexes (black, from overlay shown in B lower 
panel) compared to chemical shift perturbation of RRM-RGG2-ZnF in binding UGGUA RNA (yellow, shown in D 
upper panel).  
  
 Figure S2. FUS ZnF binding to UGGUG, related to Figure 2. 
A) Intermolecular NOEs in ZnF:UGGUG. Intermolecular NOEs between the RNA H1’ resonances and the FUS 
resonances in a 2D f2 13C-filtered NOESY at 303K. (left) Intermolecular NOE from G2 and G3 imino H1 resonances 
and the FUS resonances in a 2D NOESY at 278K (middle). Cross sections from the 3D 1H-15N-NOESY at 278K of 
the complex showing NOEs from the exchangeable NH/NH2 resonances of Arg 422 and Asn 445. Intermolecular NOEs 
are labelled in pink. B) 1H-13C-HSQC aromatic regions of Znf free (red) and bound to UGGUG (blue) at 283K. C) 1H-
13C-HSQC spectra showing aromatic resonances of  UGGUG RNA free (red) and FUS ZnF bound (blue). D) Effect of 
U1 on chemical shift perturbations of ZnF as shows by representative residue S439. ZnF free (red) and in complex 
with 0.25 – 3.0 molar equivalents of ssRNA (colored). E) 1H-13C-HSQC spectra showing aromatic resonances of 
UGGUA RNA free (red) and bound to FUS ZnF (aqua) and resonance arising from ZnF (green). F) ITC 
measurements of ZnF titrated with UGGUG or UGGUA (right). 
  
 Figure S3. NMR spectra of RRM:RNA stem-loop hnRNPA2/B1, related to Figure 3. 
A) Intermolecular NOEs 3D 13C-filtered, 13C-edited NOESY (tm 150-ms) 13C15N RRM: 1H RNA. B) Intermolecular 
NOEs 13C-filtered, 13C-edited NOESY (tm 120-ms) in D2O 303K of 13C, 15N RNA: 15N RRM. C) Intermolecular NOEs 
of RRM:RNA stem-loop hnRNPA2/B1 ΔA11, from 3D 13C-filtered, 13C-edited NOESY (tm 80-ms) 13C15N RRM: 1H 
RNA. D) Hydrogen bonds present in β1’-β1” hairpin of FUS RRM. 
  
 
Figure S4. Effect of RGG repeats on RNA binding, related to Figure 5. 
 A) 1H-1H 2D TOCSY showing H5-H6 of pyrimidine of stem-loops free and on addition of RRM at molar equivalents 
0.5 yellow, 1.0 blue and 2.0 purple and chemical shifts differences of H5 and H6. B) Chemical shift perturbation of 
RRM (280-377, grey) and RRMRGGx3 (260-390, blue) bound to hnRNPA2/B1 stem-loop in buffers 20 mM 
NaH2PO4/Na2HPO4 2mM β-mercaptoethanol pH 6.5 and 20 mM NaH2PO4/Na2HPO4, 40 mM NaCl 2mM β-
mercaptoethanol pH 6.5 respectively. C) {1H}-15N Heteronuclear NOE at 310 K of RRMRGGx3 free (left) and in 
complex with hnRNPA2/B1 stem loop. NOE (blue/yellow), reference experiment (red), with selected assignments 
resonances from RGG2 extension (amino acids 377-390) shown. D) NMR based model of RRM-
RGGx3:hnRNPA2/B1 stem-loop showing 5 conformers showing C-terminal extension and RGG motifs (371-390, 
red), E) 15N-HSQC of RRM-RGGx3 free (grey), bound to single stranded loop of SON (blue), and bound to SON 
stem-loop (red). 
 
Figure S5. Domain contributions to binding of a bipartite motif RNA motif consisting of a stem-loop-GGU 
from SON pre-mRNA and functional analysis of RNA binding mutants, related to Figure 6 
(A)Trace amounts of SON-ggu RNA was incubated with increasing amounts of protein RRM (269-377), ZnF (418-
454) or RRM-RGG2-ZnF (269-454) and separated by electrophoresis. (-) indicate lane without protein. B) Schematic 
of FUS protein showing RRM and ZnF mutations used in this study (top). Band shift of RRM-RGG2-ZnF wt and 
mutant with GGU+SL RNAs stained with toluidine blue (bottom). C) Overlaid 15N-HSQC RRM-RGG2-ZnF mutant 
(F288A, K315A, K316A, Y325A-F428AR441A, N445A), free (red) and bound to SON-GGU RNA (blue). Inserts of 
1H-15N-HSQC spectra showing chemical shift perturbations of RRM-RGG2-ZnF WT and mutant binding to SON-
GGU RNA (right). D) RT-qPCR results indicating the relative endogenous FUS mRNA levels normalized to 5.8S 
rRNA levels of control knockdown, FUS knockdown and different FUS rescue conditions in (the forward RT-qPCR 
primer binds in the 5’UTR of endogenous FUS mRNA which is not present in the different rescue plasmids coding for 
RNAi resistant FLAG-tagged FUS). Average and standard deviations of six biological replicates are shown. E) 
Quantification of total FUS protein relative to loading control in SCN4 minor intron splicing assays. Average and 
standard deviations of six biological replicates are shown. F) Relative overexpression levels of different exogenous 
FLAG-FUS constructs (empty vector control, WT-FUS, mut-RRM, mut-ZnF, mut-RRM/ZnF) in HeLa WT cells used 
for the endogenous FUS mRNA level assay (Fig. 6C) are shown normalized to loading control as mean with standard 
deviation for 5 biological replicates. G) Relative overexpression levels of different exogenous FLAG-FUS constructs 
(empty vector control, WT-FUS, mut-RRM, mut-ZnF, mut-RRM/ZnF) in HeLa WT and KO cells used for the 
eTAF15 mRNA level assay (Fig. 6D) are shown normalized to loading control as mean with standard deviation for 4 
biological replicates. 
 
 
  
  
 
Supplementary Figure 6. SDS gel of various FUS constructs used in this study, related to STAR Method. 
 
 
 
  
 
Table S1. Intermolecular NOEs from FUS ZnF:UGGUG at 303 K and 278 K, related to Figure 2. 
RNA residue RRM Residue Distance 
Number Type Atom Number Type Atom  
303 K 
 440 TRP   HD1  101 URA  H1'   5.00  
 440 TRP   HE1  101 URA  H1'   5.00  
 440 TRP   HZ2  101 URA  H1'   4.00  
 440 TRP   HH2  101 URA  H1'   6.00  
 440 TRP   HZ2  101 URA  H2'   4.00  
 440 TRP   HH2  101 URA  H2'   5.00  
 440 TRP   HZ3  101 URA  H5    5.00  
 440 TRP   HH2  101 URA  H5    6.00  
 420 GLN   QG   102 RGUA H1'   4.00  
 420 GLN   HB2  102 RGUA H1'   5.00  
 420 GLN   HB3  102 RGUA H1'   5.00  
 422 ARG   QG   102 RGUA H1'   5.00  
 422 ARG   HD3  102 RGUA H1'   6.00  
 422 ARG   HD2  102 RGUA H1'   6.00  
 438 PHE   QD   102 RGUA H1'   6.00  
 438 PHE   QE   102 RGUA H1'   5.00  
 438 PHE   HZ   102 RGUA H1'   5.00  
 438 PHE   QE   102 RGUA H2'   3.00  
 438 PHE   HZ   102 RGUA H2'   3.00  
 438 PHE   QE   102 RGUA H3'   4.00  
 438 PHE   QD   102 RGUA H3'   6.00  
 438 PHE   HZ   102 RGUA H3'   6.00  
 438 PHE   QD   102 RGUA H8    6.00  
 438 PHE   QE   102 RGUA H8    5.00  
 438 PHE   HB2  102 RGUA H8    6.00  
 438 PHE   HB3  102 RGUA H8    6.00  
 440 TRP   HZ2  102 RGUA H8    5.00  
 440 TRP   HE1  102 RGUA H8    4.00  
 440 TRP   HD1  102 RGUA H8    5.00  
 438 PHE   HZ   103 RGUA H51   5.00  
 438 PHE   HZ   103 RGUA H52   5.00  
 438 PHE   QE   103 RGUA H51   4.00  
 438 PHE   QE   103 RGUA H52   5.00  
 438 PHE   QD   103 RGUA H1'   6.00  
 438 PHE   QE   103 RGUA H1'   6.00  
 438 PHE   QD   103 RGUA H8    5.00  
 438 PHE   QE   103 RGUA H8    4.00  
 438 PHE   HZ   103 RGUA H8    6.00  
 445 ASN   QD2  104 URA  H5    5.00 
278 K 
 440 TRP   HE1  102 RGUA H8    5.00  
 440 TRP   HE1  102 RGUA H1'   6.00  
 422 ARG   HE   102 RGUA H1'   5.50  
 422 ARG   HE   102 RGUA H2'   5.50  
 422 ARG   QH2  102 RGUA H1'   6.00  
 422 ARG   QH2  102 RGUA H4'   6.00  
 422 ARG   QH1  102 RGUA H3'   6.00  
 439 SER   H    102 RGUA H1    5.50  
 422 ARG   H    102 RGUA H1    5.00  
 438 PHE   QD   102 RGUA H1    4.00  
 438 PHE   HA   102 RGUA H1    4.50  
 422 ARG   HB2  102 RGUA H1    4.50  
 422 ARG   HB3  102 RGUA H1    4.00  
 422 ARG   QG   102 RGUA H1    4.00  
 422 ARG   HD2  102 RGUA H1    5.50  
 422 ARG   HD3  102 RGUA H1    6.00  
 438 PHE   H    103 RGUA H1    3.50  
 435 ASN   HD21 103 RGUA H1    5.50  
 435 ASN   HD22 103 RGUA H1    5.00  
 437 ASN   HA   103 RGUA H1    3.00  
 436 MET   QB   103 RGUA H1    5.00  
 437 ASN   HB2  103 RGUA H1    5.00  
 437 ASN   HB3  103 RGUA H1    6.00  
 445 ASN   HD21 104 URA  H5    3.50  
 445 ASN   HD22 104 URA  H5    4.00  
 445 ASN   HD22 103 RGUA H8    5.50  
 441 ARG   HE   103 RGUA H1    6.00  
 441 ARG   HE   103 RGUA H8    5.00  
 441 ARG   QH2  103 RGUA H8    6.00  
       
 
  
Table S2. Intermolecular NOEs from FUS RRM (280-377) in complex with hnRNP A2/B1 and ΔA11 RNA 
stem-loops, related to Figure 3. 
RNA residue RRM Residue Distance 
Number Type Atom Number Type Atom  
 12  RADE  H8    325  TYR   QD    6.00   
 12  RADE  H8    325  TYR   QE    5.50   
 12  RADE  H8    328  ARG   QD    5.50   
 12  RADE  H8    328  ARG   QG    6.00   
 12  RADE  H2    325  TYR   QD    4.00   
 12  RADE  H2    325  TYR   QE    3.00   
 12  RADE  H2    323  ASN   HB2   5.00   
 12  RADE  H2    323  ASN   HB3   5.00   
 12  RADE  H1'   325  TYR   QD    5.00   
 12  RADE  H1'   325  TYR   QE    5.00   
 12  RADE  H1'   377  ARG   QD    6.00   
 12  RADE  H4'   377  ARG   QD    5.00   
 13  URA   H1'   325  TYR   QE    3.50   
 13  URA   H1'   325  TYR   QD    2.80   
 13  URA   H1'   325  TYR   HB2   5.50   
 13  URA   H1'   325  TYR   HB3   5.50   
 13  URA   H1'   334  LYS   HE3   6.00   
 13  URA   H1'   334  LYS   QD    6.00   
 13  URA   H4'   325  TYR   QE    3.50   
 13  URA   H4'   325  TYR   QD    4.50   
 13  URA   H3'   372  ARG   QD    3.00   
 14  URA   H3'   372  ARG   HB2   4.00   
 14  URA   H3'   372  ARG   HB3   4.00   
 14  URA   H3'   372  ARG   QG    3.50   
 13  URA   H5    328  ARG   QD    4.00   
 13  URA   H5    328  ARG   QG    4.00   
 13  URA   H5    328  ARG   QB    4.00   
 13  URA   H6    328  ARG   QD    6.00   
 14  URA   H5    288  PHE   QE    4.00   
 14  URA   H5    288  PHE   HZ    4.00   
 14  URA   H5    338  THR   QG2   6.00   
 14  URA   H1'   288  PHE   QD    3.00   
 14  URA   H1'   288  PHE   QE    4.50   
 14  URA   H1'   338  THR   QG2   3.00   
 14  URA   H1'   338  THR   HB    6.00   
 14  URA   H1'   369  ALA   QB    3.00   
 14  URA   H1'   369  ALA   HA    6.00   
 14  URA   H1'   286  THR   QG2   4.00   
 14  URA   H1'   286  THR   HB    6.00   
 14  URA   H1'   370  THR   QG2   5.00   
 14  URA   H1'   370  THR   HA    6.00   
 14  URA   H4'   325  TYR   QE    4.50   
 14  URA   H4'   325  TYR   QD    5.50   
 14  URA   H4'   338  THR   QG2   3.00   
 14  URA   H4'   286  THR   QG2   5.50   
 14  URA   H4'   369  ALA   QB    5.00   
 15  RCYT  H1'   286  THR   QG2   4.00   
 15  RCYT  H1'   321  MET   QE    4.00   
 15  RCYT  H1'   338  THR   QG2   6.00   
 15  RCYT  H2'   286  THR   QG2   5.00   
 15  RCYT  H2'   321  MET   QE    6.00   
 15  RCYT  H2'   371  ARG   QD    3.00   
 15  RCYT  H2'   371  ARG   QG    6.00   
 15  RCYT  H4'   321  MET   QE    5.00   
 15  RCYT  H4'   338  THR   QG2   4.00   
 15  RCYT  H4'   286  THR   QG2   4.50   
 15  RCYT  H5    369  ALA   QB    4.00   
 15  RCYT  H5    371  ARG   QD    6.00   
 15  RCYT  H5    371  ARG   QG    6.00   
 15  RCYT  H6    371  ARG   QD    5.50   
 15  RCYT  H6    371  ARG   QG    6.00   
 15  RCYT  H6    369  ALA   QB    4.00   
 15  RCYT  H6    286  THR   QG2   4.00   
 15  RCYT  H5'   338  THR   QG2   4.00   
 15  RCYT  H5"   338  THR   QG2   4.00   
 16  URA   H4'   321  MET   QE    5.00   
 16  URA   H5'   321  MET   QE    6.00   
 16  URA   H5"   321  MET   QE    6.00   
 16  URA   H5    321  MET   QE    6.00   
 16 URA   H6    321  MET   QE    6.00   
 16 URA   H1'   321  MET   QE    6.00   
 17  RADE  H8    316  LYS   QG    6.00   
       
Additional Intermolecular NOEs present in hnRNP A2/B1 complex interpreted as arising from a minor form  
 12  RADE  H2   369  ALA   QB     
 12  RADE  H1’   369  ALA   QB     
 12  RADE  H2   370  THR  QG2     
 13 URA H1’ 321 MET QE  
 
 
  
Table S3. ITC measurements of FUS constructs and RNA species in 20 mM Na2HPO4/NaH2PO4, 40 mM NaCl, 
1 mM β-mercaptoethanol, pH 6.5 at 30 oC, related to Figure 4. We have modelled these measurements as Kdapp and 
ΔGapp as a number of samples have multiple binding events (*) 
FUS amino acids RNA Kdapp,  
(μM) 
 
ΔGapp= 
ΔH-TΔS 
(kcal/mol) 
ΔHapp  
(kcal/mol) 
 
-TΔS 
(kcal/mol) 
N 
RRM 280-377 hnRNPA2/B1 SL 116  ± 2.7 -4093 -1.1 ± 0.1 5.15 = 1 
 269-377 hnRNPA2/B1 SL 84.0  ± 1.2 -5648 -17.3± 0.3 11.7 1.06 
 269-377 mut 
F288A/Y325A/K315A/K316A 
hnRNPA2/B1 SL n.d. n.d. n.d. n.d. n.d. 
RRM-
RGGx3 
269-390 hnRNPA2/B1 SL 13.9  ± 0.2* -6744* -13.0 ±0.7 6.30 1.64 
 260-390 hnRNPA2/B1 SL 10.1  ± 0.6* -6941* -15.5 ±0.4 8.58 1.44 
 260-390 SON SL 13.1  ± 0.7* -6759* -19.3 ± 0.4 12.5 1.58 
 260-390 ACGCGC  27.2  ± 2.6 -4691 -5.5 ± 0.5 0.82 0.99 
 260-390 AAUAAA 120  ± 5.9 -8763 -5.8 ± 0.2 0.34 = 1 
 260-390 mut  
N284A/N285A 
hnRNPA2/B1 SL 10.5 ± 0.2*  -6912* 
 
-16.4 ± 0.4  3.6 1.74 
 260-390 mut  
N314A/Q319A/M321A 
hnRNPA2/B1 SL 7.0 ± 0.2*  -7151* 
 
-19.5 ± 0.4 12.4 1.65 
 260-390 mut  
R371A/R372A  
hnRNPA2/B1 SL 28.8 ± 0.9* -3024* -4.6 ± 0.09 1.64 1.66 
 260-390 mut 
K315A/K316A 
hnRNPA2/B1 SL 23.2 ± 0.6* -6432* -10.1 ±0.2  3.7 1.73 
 260-390 mut 
F288A/Y325A/K315A/K316A 
hnRNPA2/B1 SL 46 ± 2* -6024* 
 
-16.2 ± 1.5  10.2 1.77 
ZnF 318-454 UGGUA 29.8  ± 1.2 -31411 -18.9 ± 0.8 12.6 1.16 
  318-454 UGGUG 29.5  ± 3.0 -32165 -19.2 ±0.2 12.9 1.34 
 
 
 
  
Table S4: RNA and ssDNA sequences used for structural studies. Nucleotides included to stabilize the stem are 
underlined. Related to STAR Method 
Name Sequence Preparation 
SON – SL GGAUCUUUAACUACUCAAGAUCC T7 transcription 
SON-GGU GGATCTTTAACTACTCAAGATACTGAACA
TGACATGGTA 
T7 transcription 
hnRNPA2/B1 SL  GGCAGAUUACAAUUCUAUUUGCC T7 transcription 
hnRNPA2/B1 ΔA11 SL GGCAGAUUACAUUCUAUUUGCC  
GGU-hnRNPA2/B1 GATTAGGTTTTGTGAGTAGACAGATTACA
ATTCTATTTTAA 
T7 transcription 
ssSON UAACUACUC Chemical synthesis 
ACGCGC ACGCGC Chemical synthesis 
AUU rich AUUAUUAUUAUU Chemical synthesis 
GGUG GGUG Chemical synthesis 
UGGUG UGGUG Chemical synthesis 
UGGUA UGGUA Chemical synthesis 
GUGGU GUGGU Chemical synthesis 
AAUAAA AAUAAA Chemical synthesis 
ssDNA1 TCCCCGT Chemical synthesis 
ssDNA2 AAAGTGTC Chemical synthesis 
ssDNA3 AGGTTCTA Chemical synthesis 
 
  
Table S5: Primers used for Splicing assays related to STAR Method 
Name Oligonucleotide sequence assay 
F288A CAGACAACAACACCATCGCTGTGCAAGGCCTGGGTG mutation 
K315A;K3
16A 
GCCAAATTAATCATGGGCTGTCCCGTTGCTGCGTTTGTCTTAA
TAATACCAATCTGCTTGAAGTAATCA 
mutation 
Y325A 5’-GGACAGCCCATGATTAATTTGGCCACAGACAGGGAAACTG-
3’  
mutation 
F348A; 
R441A; 
N445A 
GTTTAGGGGCCTTACACTGGGCGCATTCATTCGCCCAAGAGGC
GTTCATATTCTCAC 
mutation 
   
TAF15: GCCTCCTATGCAGCTCAGTC, GGTTGTAACCCCCTGTGCTA; 
 
mRNA 
levels 
FLAG-
FUS: 
CAAGGACGACGACGACAA, ACTGCTCTGCTGGGAATAGC; 
 
mRNA 
levels 
end.human
FUS: 
GTGGTGGCAGAGGAGGCTATGATCG, 
CAGGACAAAAAGCTGTTCCAG; 
mRNA 
levels 
NDRG2: CAGGAGGTGCAGATCACAGA, AGTCCCACATCGTGGTAGGT; 
 
mRNA 
levels 
NDRG2: AGTCCCACATCGTGGTAGGT; mRNA 
levels 
MAG: GTCCTGTTCAGCAGCGACTT, AGCGTGTAGCTGTCCTTGGT; mRNA 
levels 
KCND3: GGCAAGACCACCTCACTCAT, GCTGGACAGTGAGGGACTTC; mRNA 
levels 
ACTINB: AGAAAATCTGGCACCACACC, AGAGGCGTACAGGGATAGCA; mRNA 
levels 
HMBS: GGCAATGCGGCTGCA, GGGTACCCACGCGAATCAC; mRNA 
levels 
HPRT1: TGACACTGGCAAAACAATGCA, 
GGTCCTTTTCACCAGCAAGCT; 
mRNA 
levels 
SDHA: TGGGAACAAGAGGGCATCTG, CCACCACTGCATCAAATTCAT; mRNA 
levels 
UBC: ATTTGGGTCGCGGTTCTT, TGCCTTGACATTCTCGATGGT; mRNA 
levels 
 
 
  
Table S6: qPCR Primers used for Splicing assays related to STAR Method 
 
primer  5’-sequence-3’ Use 
sybr SCN4A f ACAAGGGCAAGGCCATCTTC qPCR (both SCN4A assays) 
sybr SCN4Aspl r CATGCTGAACAGCGCATGG qPCR (SCN4A spliced) 
sybr SCN4Aun r GGTCAAGGAAAGTGAGGAAGCAG qPCR (SCN4A unspliced) 
5.8S rRNA fwd GGTGGATCACTCGGCTCGT qPCR (normalizer) 
5.8S rRNA rev GCAAGTGCGTTCGAAGTGTC qPCR (normalizer) 
sybr FUS f AGCGGTGTTGGAACTTCG qPCR (specific for 
endogenous FUS mRNA) 
sybr FUS r GACTGCTCTGCTGGGAATAG qPCR (specific for 
endogenous FUS mRNA 
 
